Go Pro
→ Forget SpaceX. THIS is Elon’s next BIG bet (From Brownstone Research) (Ad)tc pixel Free SLSN Stock Alerts

Solesence (SLSN) Financials

Solesence logo
$0.78 -0.01 (-0.68%)
Closing price 07/17/2026 04:00 PM Eastern
Extended Trading
$0.75 -0.03 (-3.74%)
As of 07/17/2026 07:29 PM Eastern
Extended trading is trading that happens on electronic markets outside of regular trading hours. This is a fair market value extended hours price provided by Massive. Learn more.
Compare
Annual Income Statements for Solesence

Annual Income Statements for Solesence

This table shows Solesence's income and expenses over time, based on annual financial data. All values are USD millions unless otherwise specified.

Metric 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 2025
Period end date 12/31/2015 12/31/2016 12/31/2017 12/31/2018 12/31/2019 12/31/2020 12/31/2021 12/31/2022 12/31/2023 12/31/2024 12/31/2025
Net Income / (Loss) Attributable to Common Shareholders		 -1.19 -1.28 4.06 -2.08 -3.01 0.99 2.32 -2.62 -4.39 4.24 1.79
Consolidated Net Income / (Loss)		 -1.19 -1.28 -0.79 -2.08 -3.01 0.99 2.32 -2.62 -4.39 4.24 1.79
Net Income / (Loss) Continuing Operations		 -1.19 -1.28 4.06 -2.08 -3.01 0.99 2.32 -2.62 -4.39 4.24 1.79
Total Pre-Tax Income 		-1.19 -1.28 -0.79 -2.08 -3.01 0.99 2.36 -2.64 -4.38 4.46 1.86
Total Operating Income		 -1.18 -1.27 -0.77 -2.02 -2.80 1.49 2.56 -2.26 -3.55 5.13 1.57
Total Gross Profit		 3.11 3.24 3.85 3.29 2.62 5.99 8.69 8.36 7.83 16 16
Total Revenue		 10 11 17 14 13 17 29 37 37 52 62
Operating Revenue		 10 11 17 14 13 17 29 37 37 52 62
Total Cost of Revenue		 7.20 7.54 8.62 11 9.89 11 21 29 29 36 46
Operating Cost of Revenue		 7.20 7.54 8.62 11 9.89 11 21 29 29 36 46
Total Operating Expenses		 4.29 4.51 4.62 5.31 5.41 4.51 6.13 11 11 11 14
Selling, General & Admin Expense		 3.02 2.95 2.89 3.26 3.54 2.93 3.90 7.58 7.53 7.22 10
Research & Development Expense		 1.27 1.55 1.74 2.06 1.87 1.57 2.24 3.04 3.84 3.84 4.09
Total Other Income / (Expense), net		 -0.01 -0.02 -0.02 -0.06 -0.21 -0.50 -0.20 -0.38 -0.84 -0.67 0.29
Interest & Investment Income		 - - - - - - - - - -0.67 -0.93
Other Income / (Expense), net		 - - 0.02 - - - 0.95 - - 0.00 1.22
Income Tax Expense		 - - 0.00 - 0.00 0.00 0.04 -0.02 0.01 0.23 0.07
Basic Earnings per Share		 ($0.04) ($0.04) ($0.03) ($0.06) ($0.08) $0.03 $0.05 ($0.05) ($0.09) $0.07 $0.03
Weighted Average Basic Shares Outstanding		 28.57M 30.91M 31.34M 33.87M 36.60M 38.16M 45.02M 49.12M 49.56M 62.35M 70.34M
Diluted Earnings per Share		 ($0.04) ($0.04) ($0.03) ($0.06) ($0.08) $0.03 $0.05 ($0.05) ($0.09) $0.07 $0.02
Weighted Average Diluted Shares Outstanding		 28.57M 30.91M 31.34M 33.87M 36.60M 38.55M 47.04M 49.12M 49.56M 65.03M 72.58M
Weighted Average Basic & Diluted Shares Outstanding		 28.57M 30.91M 31.34M 33.87M 36.60M 38.22M 48.89M 49.51M 54.80M 70.10M 70.63M

Quarterly Income Statements for Solesence

This table shows Solesence's income and expenses over time, based on quarterly financial data. All values are USD millions unless otherwise specified.

Metric Q3 2023 Q4 2023 Q1 2024 Q2 2024 Q3 2024 Q4 2024 Q1 2025 Q2 2025 Q3 2025 Q4 2025 Q1 2026
Period end date 9/30/2023 12/31/2023 3/31/2024 6/30/2024 9/30/2024 12/31/2024 3/31/2025 6/30/2025 9/30/2025 12/31/2025 3/31/2026
Net Income / (Loss) Attributable to Common Shareholders		 -1.44 -2.13 0.89 0.86 3.05 -0.56 0.08 2.67 -1.12 0.16 -0.77
Consolidated Net Income / (Loss)		 -1.44 -2.13 0.89 0.86 3.05 -0.56 0.08 2.67 -1.12 0.16 -0.77
Net Income / (Loss) Continuing Operations		 -1.44 -2.13 0.89 0.86 3.05 -0.56 0.08 2.67 -1.12 0.16 -0.77
Total Pre-Tax Income 		-1.44 -2.12 0.89 0.86 3.05 -0.33 0.08 3.06 -1.12 -0.15 -0.77
Total Operating Income		 -1.22 -1.90 1.11 1.05 3.20 -0.22 0.26 1.91 -0.78 0.19 -0.50
Total Gross Profit		 1.53 0.47 3.58 3.74 6.10 2.77 3.38 5.88 3.37 3.43 3.34
Total Revenue		 7.96 8.01 9.87 13 17 13 15 20 15 12 13
Operating Revenue		 7.96 8.01 9.87 13 17 13 15 20 15 12 13
Total Cost of Revenue		 6.43 7.54 6.29 9.31 11 9.80 11 14 11 9.05 9.62
Operating Cost of Revenue		 6.43 7.54 6.29 9.31 11 9.80 11 14 11 9.05 9.62
Total Operating Expenses		 2.75 2.37 2.47 2.69 2.90 2.99 3.13 3.97 4.15 3.25 3.84
Selling, General & Admin Expense		 1.70 1.58 1.56 1.83 1.93 1.90 2.11 3.01 3.07 2.21 2.80
Research & Development Expense		 1.06 0.79 0.91 0.86 0.97 1.09 1.02 0.96 1.08 1.04 1.04
Total Other Income / (Expense), net		 -0.21 -0.22 -0.22 -0.19 -0.15 -0.11 -0.18 1.15 -0.34 -0.34 -0.26
Interest & Investment Income		 - - - -0.19 -0.15 - -0.18 -0.09 -0.34 - -0.26
Other Income / (Expense), net		 - - - 0.00 0.00 - 0.00 1.23 0.00 - 0.00
Income Tax Expense		 0.00 0.01 0.00 0.00 0.00 0.23 0.00 0.39 0.00 -0.32 0.00
Basic Earnings per Share		 ($0.03) ($0.05) $0.02 $0.02 $0.04 ($0.01) $0.00 $0.04 ($0.02) $0.01 ($0.01)
Weighted Average Basic Shares Outstanding		 49.60M 49.56M 52.68M 56.67M 69.87M 62.35M 70.10M 70.20M 70.50M 70.34M 70.63M
Diluted Earnings per Share		 ($0.03) ($0.05) $0.02 $0.01 $0.04 - $0.00 $0.04 ($0.02) - ($0.01)
Weighted Average Diluted Shares Outstanding		 49.60M 49.56M 58.04M 58.71M 71.94M 65.03M 72.63M 72.58M 70.50M 72.58M 70.63M
Weighted Average Basic & Diluted Shares Outstanding		 49.63M 54.80M 54.86M 69.86M 69.99M 70.10M 70.10M 70.48M 70.54M 70.63M 70.63M

Annual Cash Flow Statements for Solesence

This table details how cash moves in and out of Solesence's business through operations, investing, and financing, using annual figures. All values are USD millions unless otherwise specified.

Metric 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 2025
Period end date 12/31/2015 12/31/2016 12/31/2017 12/31/2018 12/31/2019 12/31/2020 12/31/2021 12/31/2022 12/31/2023 12/31/2024 12/31/2025
Net Change in Cash & Equivalents		 -0.59 0.50 0.18 -0.61 -0.15 -0.24 -0.30 1.53 -0.46 -0.31 -0.12
Net Cash From Operating Activities		 -0.24 -0.24 -0.96 -1.34 -2.78 -2.06 2.32 -1.65 -2.01 1.97 -8.57
Net Cash From Continuing Operating Activities		 -0.24 -0.24 -0.94 -1.34 -2.78 -2.06 2.32 -1.65 -2.01 1.97 -8.57
Net Income / (Loss) Continuing Operations		 -1.19 -1.28 -0.79 -2.08 -3.01 0.99 2.32 -2.62 -4.39 4.24 1.79
Consolidated Net Income / (Loss)		 -1.19 -1.28 -0.79 -2.08 -3.01 0.99 2.32 -2.62 -4.39 4.24 1.79
Depreciation Expense		 0.74 0.61 0.34 0.32 0.32 0.36 0.45 0.57 0.74 0.93 0.90
Non-Cash Adjustments To Reconcile Net Income		 0.18 0.26 0.17 0.20 0.26 0.20 -0.79 0.63 0.77 0.73 0.58
Changes in Operating Assets and Liabilities, net		 0.04 0.17 -0.69 0.21 -0.37 -3.87 -0.56 -0.22 0.87 -3.92 -12
Net Cash From Investing Activities		 -0.29 -0.17 -0.07 -0.16 -0.74 -0.88 -1.87 -2.82 -1.05 -4.56 -2.14
Net Cash From Continuing Investing Activities		 -0.29 -0.17 -0.07 -0.16 -0.74 -0.88 -1.87 -2.82 -1.05 -4.56 -2.14
Purchase of Property, Plant & Equipment		 -0.29 -0.17 -0.21 -0.16 -0.74 -0.88 -1.87 -2.82 -1.05 -4.56 -2.14
Net Cash From Financing Activities		 -0.06 0.91 1.21 0.89 3.37 2.70 -0.75 6.00 2.59 2.27 11
Net Cash From Continuing Financing Activities		 -0.06 0.91 1.21 0.89 3.37 2.70 -0.75 6.00 2.59 2.27 11
Repayment of Debt		 -0.09 -0.10 -0.14 -1.64 -11 -15 -27 2.93 -2.82 -6.01 0.00
Issuance of Debt		 - - 0.30 2.17 13 17 25 3.00 5.34 0.20 10
Issuance of Preferred Equity		 - - - - - - - - 0.00 6.00 0.00
Issuance of Common Equity		 - 0.99 1.00 - 1.68 - - - - 2.08 0.32
Cash Interest Paid		 0.01 0.02 0.03 0.05 0.17 0.18 0.22 0.33 0.75 0.64 1.02
Cash Income Taxes Paid		 - - - - - - - - - 0.00 0.00

Quarterly Cash Flow Statements for Solesence

This table details how cash moves in and out of Solesence's business through operations, investing, and financing, using quarterly figures. All values are USD millions unless otherwise specified.

Metric Q3 2023 Q4 2023 Q1 2024 Q2 2024 Q3 2024 Q4 2024 Q1 2025 Q2 2025 Q3 2025 Q4 2025 Q1 2026
Period end date 9/30/2023 12/31/2023 3/31/2024 6/30/2024 9/30/2024 12/31/2024 3/31/2025 6/30/2025 9/30/2025 12/31/2025 3/31/2026
Net Change in Cash & Equivalents		 -1.01 0.53 0.30 0.34 0.57 -1.52 0.41 2.29 -3.68 0.86 -0.72
Net Cash From Operating Activities		 2.61 -2.65 -3.86 -0.57 4.20 2.19 -7.22 -0.65 -2.51 1.82 1.52
Net Cash From Continuing Operating Activities		 2.61 -2.65 -3.86 -0.57 4.20 2.19 -7.22 -0.65 -2.51 1.82 1.52
Net Income / (Loss) Continuing Operations		 -1.44 -2.13 0.89 0.85 3.05 -0.56 0.08 2.67 -1.12 0.16 -0.77
Consolidated Net Income / (Loss)		 -1.44 -2.13 0.89 0.85 3.05 -0.56 0.08 2.67 -1.12 0.16 -0.77
Depreciation Expense		 0.18 0.22 0.23 0.24 0.23 0.23 0.23 0.23 0.23 0.22 0.31
Non-Cash Adjustments To Reconcile Net Income		 0.19 0.18 0.16 0.16 0.16 0.25 0.13 0.12 0.12 0.21 0.08
Changes in Operating Assets and Liabilities, net		 3.68 -0.92 -5.14 -1.81 0.77 2.27 -7.65 -3.67 -1.74 1.23 1.89
Net Cash From Investing Activities		 -0.04 -0.20 -0.09 -0.48 -1.40 -2.59 0.13 -1.41 -0.42 -0.45 -0.53
Net Cash From Continuing Investing Activities		 -0.04 -0.20 -0.09 -0.48 -1.40 -2.59 0.13 -1.41 -0.42 -0.45 -0.53
Purchase of Property, Plant & Equipment		 -0.04 -0.20 -0.09 -0.48 -1.40 -2.59 0.13 -1.41 -0.42 -0.45 -0.53
Net Cash From Financing Activities		 -3.57 3.38 4.24 1.38 -2.23 -1.11 7.50 4.35 -0.75 -0.51 -1.70
Net Cash From Continuing Financing Activities		 -3.57 3.38 4.24 1.38 -2.23 -1.11 7.50 4.35 -0.75 -0.51 -1.70
Repayment of Debt		 -9.09 23 -3.96 -13 -2.27 14 0.00 - - - -1.72
Issuance of Debt		 5.50 -19 0.20 15 - -15 7.49 4.11 -0.79 -0.55 0.00
Issuance of Common Equity		 - - 2.00 -0.04 0.04 0.09 0.00 0.25 0.04 0.04 0.02
Cash Interest Paid		 0.24 0.20 0.16 0.18 0.18 0.12 0.10 0.26 0.34 0.33 0.17

Annual Balance Sheets for Solesence

This table presents Solesence's assets and liabilities at the end of each period, using annual balance sheet data. All values are USD millions unless otherwise specified.

Metric 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 2025
Period end date 12/31/2015 12/31/2016 12/31/2017 12/31/2018 12/31/2019 12/31/2020 12/31/2021 12/31/2022 12/31/2023 12/31/2024 12/31/2025
Total Assets		 4.57 4.84 6.27 6.57 9.37 14 28 34 33 50 50
Total Current Assets		 2.69 3.43 4.62 4.69 4.99 8.84 12 17 16 29 29
Cash & Equivalents		 1.28 1.78 1.96 1.35 1.19 0.96 0.66 2.19 1.72 1.41 1.29
Accounts Receivable		 0.51 0.43 1.12 0.83 0.97 2.93 3.94 4.73 3.47 4.87 6.84
Inventories, net		 0.66 0.77 1.39 2.24 2.55 4.34 6.10 8.84 10 20 19
Prepaid Expenses		 0.25 0.44 0.17 0.27 0.27 0.61 0.91 0.87 1.08 2.80 2.14
Plant, Property, & Equipment, net		 1.86 1.40 1.62 1.87 2.26 2.87 4.71 7.95 8.67 13 14
Total Noncurrent Assets		 0.02 0.02 0.02 0.02 2.13 1.84 12 8.98 7.91 7.92 6.95
Other Noncurrent Operating Assets		 0.02 0.02 0.02 0.02 2.13 1.84 12 8.98 7.91 7.92 6.95
Total Liabilities & Shareholders' Equity		 4.57 4.84 6.27 6.57 9.37 14 28 34 33 50 50
Total Liabilities		 1.71 2.05 3.03 5.19 7.86 11 21 28 31 35 32
Total Current Liabilities		 0.88 1.30 2.02 3.64 4.41 6.78 7.34 14 16 26 14
Short-Term Debt		 0.09 0.11 0.44 0.22 1.00 1.00 1.35 4.28 6.11 1.00 4.77
Accounts Payable		 0.51 0.67 1.04 2.44 1.97 4.28 3.57 6.36 6.26 9.09 4.10
Accrued Expenses		 0.28 0.52 0.54 0.97 0.38 0.48 0.95 1.02 0.87 4.85 2.88
Current Deferred Revenue		 - - - 0.01 0.48 0.41 0.78 2.17 2.35 5.57 0.93
Other Current Liabilities		 - - - - 0.58 0.61 0.69 0.00 0.00 5.26 1.26
Total Noncurrent Liabilities		 0.84 0.75 1.01 1.55 3.45 4.02 14 14 15 9.28 18
Long-Term Debt		 - - - - 0.00 0.95 1.00 4.00 6.00 0.00 11
Asset Retirement Reserve & Litigation Obligation		 0.17 0.18 0.18 0.20 0.21 0.21 0.22 0.23 0.24 0.25 0.19
Other Noncurrent Operating Liabilities		 - - - 0.51 2.04 1.65 12 9.82 9.15 9.04 7.80
Total Equity & Noncontrolling Interests		 2.86 2.79 3.23 1.38 1.51 2.73 7.47 5.65 1.90 15 18
Total Preferred & Common Equity		 2.86 2.79 3.23 1.38 1.51 2.73 7.47 5.65 1.90 15 18
Preferred Stock		 0.00 0.00 - - 0.00 0.00 0.00 0.00 0.00 0.00 0.00
Total Common Equity		 2.86 2.79 3.23 1.38 1.51 2.73 7.47 5.65 1.90 15 18
Common Stock		 96 98 99 99 102 102 105 106 107 115 116
Retained Earnings		 -94 -95 -96 -98 -101 -100 -97 -100 -105 -100 -99

Quarterly Balance Sheets for Solesence

This table presents Solesence's assets and liabilities at the end of each period, using quarterly balance sheet data. All values are USD millions unless otherwise specified.

Metric Q3 2023 Q1 2024 Q2 2024 Q3 2024 Q1 2025 Q2 2025 Q3 2025 Q1 2026
Period end date 9/30/2023 3/31/2024 6/30/2024 9/30/2024 3/31/2025 6/30/2025 9/30/2025 3/31/2026
Total Assets		 32 39 41 48 57 60 54 48
Total Current Assets		 16 22 24 30 36 39 33 26
Cash & Equivalents		 1.19 2.02 2.36 2.93 1.82 4.11 0.43 0.57
Accounts Receivable		 3.20 5.28 5.93 8.73 9.09 11 9.71 6.38
Inventories, net		 10 13 14 15 22 20 19 18
Prepaid Expenses		 1.04 1.50 2.10 3.06 3.09 3.78 3.79 1.90
Plant, Property, & Equipment, net		 8.61 8.81 9.26 10 13 14 14 15
Total Noncurrent Assets		 8.19 7.62 7.33 8.06 8.01 7.63 7.26 6.64
Other Noncurrent Operating Assets		 8.19 7.62 7.33 8.06 8.01 7.63 7.26 6.64
Total Liabilities & Shareholders' Equity		 32 39 41 48 57 60 54 48
Total Liabilities		 28 28 29 33 42 42 37 31
Total Current Liabilities		 18 12 14 23 33 23 18 13
Short-Term Debt		 6.34 0.85 2.27 1.00 7.29 6.10 5.32 3.05
Accounts Payable		 6.27 6.22 5.58 6.56 9.17 6.89 4.83 4.67
Accrued Expenses		 1.13 1.35 1.80 3.21 5.27 6.15 5.30 2.51
Current Deferred Revenue		 2.62 2.59 3.08 6.23 4.62 2.17 1.20 1.17
Other Current Liabilities		 1.30 1.17 1.04 6.29 6.53 1.23 1.22 1.30
Total Noncurrent Liabilities		 11 15 15 9.59 8.98 19 19 18
Long-Term Debt		 1.00 6.20 6.20 - - 11 11 11
Asset Retirement Reserve & Litigation Obligation		 0.24 0.24 0.24 0.24 0.25 0.25 0.25 0.20
Other Noncurrent Operating Liabilities		 9.48 8.94 8.71 9.35 8.74 8.48 8.14 7.44
Total Equity & Noncontrolling Interests		 3.93 4.95 12 15 15 18 17 17
Total Preferred & Common Equity		 3.93 4.95 12 15 15 18 17 17
Preferred Stock		 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00
Total Common Equity		 3.93 4.95 12 15 15 18 17 17
Common Stock		 106 109 115 115 116 116 116 116
Retained Earnings		 -103 -104 -103 -100 -100 -98 -99 -99

Annual Metrics And Ratios for Solesence

This table displays calculated financial ratios and metrics derived from Solesence's official financial filings.

Metric 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 2025
Period end date 12/31/2015 12/31/2016 12/31/2017 12/31/2018 12/31/2019 12/31/2020 12/31/2021 12/31/2022 12/31/2023 12/31/2024 12/31/2025
DEI Shares Outstanding		 28,585,496.00 31,229,996.00 31,275,330.00 33,911,792.00 38,136,792.00 38,215,792.00 48,725,473.00 49,232,163.00 49,627,254.00 69,994,979.00 70,536,845.00
DEI Adjusted Shares Outstanding		 28,585,496.00 31,229,996.00 31,275,330.00 33,911,792.00 38,136,792.00 38,215,792.00 48,725,473.00 49,232,163.00 49,627,254.00 69,994,979.00 70,536,845.00
DEI Earnings Per Adjusted Shares Outstanding		 -0.04 -0.04 0.13 -0.06 -0.08 0.03 0.05 -0.05 -0.09 0.06 0.03
Growth Metrics		 - - - - - - - - - - -
Revenue Growth		 3.79% 4.56% 60.60% -18.04% -11.87% 36.89% 72.14% 26.61% -0.05% 40.35% 18.56%
EBITDA Growth		 54.80% -48.53% 37.54% -313.87% -44.09% 186.09% 130.71% -134.74% -65.82% 316.12% -39.09%
EBIT Growth		 31.59% -7.64% 40.46% -167.95% -38.21% 153.11% 136.43% -164.31% -57.04% 244.73% -45.56%
NOPAT Growth		 31.59% -7.64% 39.12% -162.05% -38.21% 175.87% 69.62% -162.75% -57.04% 296.23% -68.99%
Net Income Growth		 30.98% -7.63% 38.50% -163.75% -44.45% 132.90% 134.58% -213.06% -67.37% 196.47% -57.73%
EPS Growth		 33.33% 0.00% 25.00% -100.00% -33.33% 137.50% 66.67% -200.00% -80.00% 177.78% -71.43%
Operating Cash Flow Growth		 79.68% -0.42% -298.34% -39.79% -106.86% 25.76% 212.62% -171.09% -21.58% 198.26% -534.65%
Free Cash Flow Firm Growth		 62.92% 38.22% -394.67% 97.44% -9,698.38% 72.11% -68.26% -144.21% 27.42% 186.66% -693.90%
Invested Capital Growth		 -16.14% -32.62% 73.80% -64.56% 221.66% 102.63% 85.63% 28.23% 4.61% 18.31% 117.47%
Revenue Q/Q Growth		 4.68% 0.82% 41.72% -23.29% -5.77% 16.86% 9.28% 2.46% -0.67% 9.54% -0.14%
EBITDA Q/Q Growth		 55.07% -219.42% 53.45% -100.83% 7.44% 155.76% -0.18% -918.67% 0.60% 38.51% 78.74%
EBIT Q/Q Growth		 31.59% -41.52% 39.84% -73.95% 5.70% 496.39% 10.41% -220.28% -1.34% 48.45% 140.65%
NOPAT Q/Q Growth		 31.59% -41.52% 38.49% -73.95% 5.70% 751.98% -20.79% -220.28% -1.34% 41.22% 105.25%
Net Income Q/Q Growth		 31.22% -40.99% 38.65% -75.46% 3.99% 623.28% -20.22% -154.17% -3.37% 58.85% 67.60%
EPS Q/Q Growth		 33.33% -33.33% 25.00% -50.00% 11.11% 0.00% -28.57% -66.67% -28.57% 250.00% 0.00%
Operating Cash Flow Q/Q Growth		 71.19% -363.46% -27.49% -32.22% -7.51% 12.19% 3,968.33% -378.26% -244.21% 168.72% -4.51%
Free Cash Flow Firm Q/Q Growth		 43.31% -49.13% -51.32% 97.45% -170.98% 64.87% -334.04% -88.32% 12.07% 815.64% 16.47%
Invested Capital Q/Q Growth		 -20.83% -34.38% 9.48% -70.82% 30.91% 0.26% 24.24% 29.19% 21.88% 9.76% -3.07%
Profitability Metrics		 - - - - - - - - - - -
Gross Margin		 30.19% 30.05% 22.23% 23.18% 20.91% 34.98% 29.48% 22.40% 20.98% 30.92% 25.88%
EBITDA Margin		 -4.30% -6.10% -2.37% -11.98% -19.59% 12.32% 16.52% -4.53% -7.52% 11.58% 5.95%
Operating Margin		 -11.42% -11.76% -4.46% -14.25% -22.35% 8.67% 8.68% -6.05% -9.51% 9.80% 2.53%
EBIT Margin		 -11.42% -11.76% -4.36% -14.25% -22.35% 8.67% 11.91% -6.05% -9.51% 9.80% 4.50%
Profit (Net Income) Margin		 -11.56% -11.90% -4.56% -14.66% -24.03% 5.78% 7.87% -7.03% -11.77% 8.09% 2.88%
Tax Burden Percent		 100.00% 100.00% 100.00% 100.00% 100.00% 100.00% 98.43% 99.36% 100.14% 94.91% 96.08%
Interest Burden Percent		 101.19% 101.18% 104.50% 102.87% 107.51% 66.60% 67.13% 116.92% 123.63% 86.94% 66.68%
Effective Tax Rate		 0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 1.57% 0.00% 0.00% 5.09% 3.92%
Return on Invested Capital (ROIC)		 -41.24% -58.15% -32.12% -97.90% -122.63% 40.30% 35.75% -15.12% -20.66% 36.32% 6.55%
ROIC Less NNEP Spread (ROIC-NNEP)		 -14.11% -27.72% -13.41% -20.72% -828.89% 8.57% 25.54% -41.89% -43.81% 23.57% 10.67%
Return on Net Nonoperating Assets (RNNOA)		 5.70% 12.75% 5.92% 7.73% -85.04% 6.31% 9.76% -24.88% -95.62% 13.96% 4.44%
Return on Equity (ROE)		 -35.55% -45.40% -26.20% -90.16% -207.67% 46.62% 45.50% -40.00% -116.28% 50.27% 10.99%
Cash Return on Invested Capital (CROIC)		 -23.69% -19.17% -86.03% -2.56% -227.77% -27.52% -24.21% -39.86% -25.17% 19.54% -67.46%
Operating Return on Assets (OROA)		 -22.86% -26.93% -13.59% -31.52% -35.08% 12.96% 16.75% -7.29% -10.67% 12.38% 5.58%
Return on Assets (ROA)		 -23.14% -27.25% -14.21% -32.43% -37.71% 8.63% 11.07% -8.47% -13.22% 10.22% 3.58%
Return on Common Equity (ROCE)		 -35.55% -45.40% -26.20% -90.16% -207.67% 46.62% 45.50% -40.00% -116.28% 50.27% 10.99%
Return on Equity Simple (ROE_SIMPLE)		 -41.66% -45.97% -24.41% -150.36% -198.94% 36.20% 31.08% -46.43% -230.81% 0.00% 0.00%
Net Operating Profit after Tax (NOPAT)		 -0.82 -0.89 -0.54 -1.42 -1.96 1.49 2.52 -1.58 -2.48 4.87 1.51
NOPAT Margin		 -8.00% -8.23% -3.12% -9.98% -15.65% 8.67% 8.55% -4.24% -6.66% 9.31% 2.43%
Net Nonoperating Expense Percent (NNEP)		 -27.13% -30.43% -18.71% -77.18% 706.26% 31.73% 10.21% 26.76% 23.15% 12.75% -4.12%
Return On Investment Capital (ROIC_SIMPLE)		 - - - - - - - - -17.72% 30.55% 4.59%
Cost of Revenue to Revenue		 69.81% 69.95% 49.78% 76.82% 79.09% 65.02% 70.52% 77.60% 79.02% 69.08% 74.12%
SG&A Expenses to Revenue		 29.27% 27.40% 16.66% 22.94% 28.32% 17.13% 13.22% 20.32% 20.20% 13.79% 16.76%
R&D to Revenue		 12.34% 14.41% 10.02% 14.49% 14.95% 9.17% 7.58% 8.14% 10.29% 7.33% 6.59%
Operating Expenses to Revenue		 41.62% 41.81% 26.69% 37.43% 43.26% 26.31% 20.80% 28.45% 30.49% 21.12% 23.35%
Earnings before Interest and Taxes (EBIT)		 -1.18 -1.27 -0.76 -2.02 -2.80 1.49 3.51 -2.26 -3.55 5.13 2.79
Earnings before Interest, Taxes, Depreciation and Amortization (EBITDA)		 -0.44 -0.66 -0.41 -1.70 -2.45 2.11 4.87 -1.69 -2.80 6.06 3.69
Valuation Ratios		 - - - - - - - - - - -
Price to Book Value (P/BV)		 4.00 7.97 5.04 17.87 6.78 11.99 27.73 9.83 15.63 10.63 6.56
Price to Tangible Book Value (P/TBV)		 4.00 7.97 5.04 17.87 6.78 11.99 27.73 9.83 15.63 10.63 6.56
Price to Revenue (P/Rev)		 1.11 2.06 0.94 1.74 0.82 1.91 7.02 1.49 0.80 3.03 1.87
Price to Earnings (P/E)		 0.00 0.00 4.02 0.00 0.00 33.13 89.21 0.00 0.00 37.51 64.67
Dividend Yield		 0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00%
Earnings Yield		 0.00% 0.00% 24.90% 0.00% 0.00% 3.02% 1.12% 0.00% 0.00% 2.67% 1.55%
Enterprise Value to Invested Capital (EV/IC)		 5.70 16.84 7.12 31.17 4.25 6.86 22.78 5.24 3.27 10.90 4.10
Enterprise Value to Revenue (EV/Rev)		 1.01 1.92 0.88 1.66 0.83 1.98 7.08 1.65 1.08 3.03 2.09
Enterprise Value to EBITDA (EV/EBITDA)		 0.00 0.00 0.00 0.00 0.00 16.05 42.86 0.00 0.00 26.15 35.15
Enterprise Value to EBIT (EV/EBIT)		 0.00 0.00 0.00 0.00 0.00 22.81 59.43 0.00 0.00 30.88 46.44
Enterprise Value to NOPAT (EV/NOPAT)		 0.00 0.00 0.00 0.00 0.00 22.81 82.84 0.00 0.00 32.53 85.90
Enterprise Value to Operating Cash Flow (EV/OCF)		 0.00 0.00 0.00 0.00 0.00 0.00 89.90 0.00 0.00 80.39 0.00
Enterprise Value to Free Cash Flow (EV/FCFF)		 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 60.46 0.00
Leverage & Solvency		 - - - - - - - - - - -
Debt to Equity		 0.08 0.08 0.27 0.16 0.85 0.75 0.31 1.47 6.37 0.07 0.87
Long-Term Debt to Equity		 0.05 0.04 0.13 0.00 0.19 0.39 0.13 0.71 3.15 0.00 0.60
Financial Leverage		 -0.40 -0.46 -0.44 -0.37 0.10 0.74 0.38 0.59 2.18 0.59 0.42
Leverage Ratio		 1.54 1.67 1.84 2.78 5.51 5.40 4.11 4.72 8.80 4.92 3.07
Compound Leverage Factor		 1.55 1.69 1.93 2.86 5.92 3.60 2.76 5.52 10.88 4.28 2.05
Debt to Total Capital		 7.68% 7.21% 21.00% 13.61% 46.02% 43.01% 23.95% 59.45% 86.42% 6.27% 46.40%
Short-Term Debt to Total Capital		 3.03% 3.56% 10.83% 13.61% 35.73% 20.86% 13.76% 30.74% 43.59% 6.27% 14.49%
Long-Term Debt to Total Capital		 4.65% 3.66% 10.17% 0.00% 10.29% 22.15% 10.19% 28.71% 42.83% 0.00% 31.91%
Preferred Equity to Total Capital		 0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00%
Noncontrolling Interests to Total Capital		 0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00%
Common Equity to Total Capital		 92.32% 92.79% 79.00% 86.39% 53.98% 56.99% 76.05% 40.55% 13.58% 93.73% 53.60%
Debt to EBITDA		 -0.54 -0.33 -2.09 -0.13 -0.53 0.98 0.48 -4.90 -4.32 0.17 4.14
Net Debt to EBITDA		 2.34 2.37 2.67 0.66 -0.04 0.52 0.35 -3.61 -3.70 -0.07 3.79
Long-Term Debt to EBITDA		 -0.33 -0.17 -1.01 0.00 -0.12 0.50 0.21 -2.37 -2.14 0.00 2.84
Debt to NOPAT		 -0.29 -0.24 -1.59 -0.15 -0.66 1.39 0.93 -5.24 -4.88 0.21 10.11
Net Debt to NOPAT		 1.26 1.76 2.03 0.80 -0.05 0.74 0.67 -3.86 -4.18 -0.08 9.26
Long-Term Debt to NOPAT		 -0.17 -0.12 -0.77 0.00 -0.15 0.72 0.40 -2.53 -2.42 0.00 6.95
Altman Z-Score		 -22.76 -19.03 -15.29 -16.63 -13.85 -6.69 2.75 -1.99 -3.08 1.38 1.16
Noncontrolling Interest Sharing Ratio		 0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00%
Liquidity Ratios		 - - - - - - - - - - -
Current Ratio		 3.06 2.64 2.28 1.29 1.13 1.30 1.58 1.20 1.05 1.14 2.07
Quick Ratio		 2.03 1.71 1.52 0.60 0.49 0.57 0.63 0.50 0.33 0.24 0.58
Cash Flow Metrics		 - - - - - - - - - - -
Free Cash Flow to Firm (FCFF)		 -0.47 -0.29 -1.45 -0.04 -3.64 -1.01 -1.71 -4.17 -3.02 2.62 -16
Operating Cash Flow to CapEx		 -83.33% -146.06% -1,333.33% -838.75% -375.14% -234.74% 123.85% -58.45% -190.87% 43.24% -399.77%
Free Cash Flow to Firm to Interest Expense		 -33.83 -19.51 -42.57 -0.64 -17.31 -2.04 -1.48 -10.91 -3.61 0.00 0.00
Operating Cash Flow to Interest Expense		 -17.14 -16.07 -28.24 -23.14 -13.22 -4.16 2.01 -4.32 -2.39 0.00 0.00
Operating Cash Flow Less CapEx to Interest Expense		 -37.71 -27.07 -30.35 -25.90 -16.74 -5.93 0.39 -11.71 -3.65 0.00 0.00
Efficiency Ratios		 - - - - - - - - - - -
Asset Turnover		 2.00 2.29 3.12 2.21 1.57 1.49 1.41 1.20 1.12 1.26 1.24
Accounts Receivable Turnover		 23.05 22.92 22.36 14.60 13.91 8.78 8.58 8.61 9.10 12.56 10.60
Inventory Turnover		 8.93 10.52 7.99 6.01 4.13 3.23 3.98 3.88 3.12 2.39 2.37
Fixed Asset Turnover		 5.16 6.62 11.47 8.14 6.07 6.68 7.78 5.89 4.49 4.89 4.59
Accounts Payable Turnover		 14.38 12.82 10.10 6.27 4.48 3.56 5.30 5.83 4.67 4.71 6.97
Days Sales Outstanding (DSO)		 15.84 15.93 16.32 25.00 26.25 41.59 42.53 42.41 40.13 29.06 34.42
Days Inventory Outstanding (DIO)		 40.87 34.70 45.66 60.71 88.47 113.01 91.62 94.12 116.85 152.92 153.84
Days Payable Outstanding (DPO)		 25.38 28.48 36.14 58.22 81.39 102.50 68.90 62.58 78.17 77.49 52.33
Cash Conversion Cycle (CCC)		 31.33 22.14 25.85 27.49 33.33 52.10 65.25 73.95 78.81 104.49 135.93
Capital & Investment Metrics		 - - - - - - - - - - -
Invested Capital		 1.82 1.23 2.14 0.76 2.44 4.93 9.16 12 12 15 32
Invested Capital Turnover		 5.16 7.06 10.29 9.81 7.84 4.65 4.18 3.57 3.10 3.90 2.69
Increase / (Decrease) in Invested Capital		 -0.35 -0.60 0.91 -1.38 1.68 2.50 4.23 2.59 0.54 2.25 17
Enterprise Value (EV)		 10 21 15 24 10 34 209 62 40 158 130
Market Capitalization		 11 22 16 25 10 33 207 56 30 159 116
Book Value per Share		 $0.10 $0.09 $0.10 $0.04 $0.04 $0.07 $0.15 $0.11 $0.04 $0.21 $0.25
Tangible Book Value per Share		 $0.10 $0.09 $0.10 $0.04 $0.04 $0.07 $0.15 $0.11 $0.04 $0.21 $0.25
Total Capital		 3.10 3.01 4.09 1.60 2.80 4.79 9.82 14 14 16 33
Total Debt		 0.24 0.22 0.86 0.22 1.29 2.06 2.35 8.28 12 1.00 15
Total Long-Term Debt		 0.14 0.11 0.42 0.00 0.29 1.06 1.00 4.00 6.00 0.00 11
Net Debt		 -1.04 -1.56 -1.10 -1.13 0.09 1.11 1.69 6.10 10 -0.41 14
Capital Expenditures (CapEx)		 0.29 0.17 0.07 0.16 0.74 0.88 1.87 2.82 1.05 4.56 2.14
Debt-free, Cash-free Net Working Capital (DFCFNWC)		 0.63 0.46 1.09 -0.08 0.38 2.09 4.95 4.89 5.10 3.17 18
Debt-free Net Working Capital (DFNWC)		 1.91 2.24 3.04 1.27 1.58 3.05 5.61 7.07 6.82 4.58 20
Net Working Capital (NWC)		 1.81 2.13 2.60 1.05 0.58 2.05 4.26 2.79 0.71 3.58 15
Net Nonoperating Expense (NNE)		 0.37 0.40 0.25 0.66 1.05 0.50 0.20 1.04 1.91 0.64 -0.28
Net Nonoperating Obligations (NNO)		 -1.04 -1.56 -1.10 -0.63 0.92 2.20 1.69 6.10 10 -0.41 14
Total Depreciation and Amortization (D&A)		 0.74 0.61 0.34 0.32 0.35 0.63 1.36 0.57 0.74 0.93 0.90
Debt-free, Cash-free Net Working Capital to Revenue		 6.13% 4.25% 6.28% -0.53% 3.05% 12.23% 16.80% 13.09% 13.67% 6.05% 29.53%
Debt-free Net Working Capital to Revenue		 18.49% 20.75% 17.57% 8.95% 12.60% 17.82% 19.03% 18.95% 18.29% 8.74% 31.60%
Net Working Capital to Revenue		 17.58% 19.75% 15.01% 7.41% 4.60% 11.98% 14.45% 7.48% 1.91% 6.83% 23.92%
Earnings Adjustments		 - - - - - - - - - - -
Adjusted Basic Earnings per Share		 ($0.04) ($0.04) ($0.03) ($0.06) ($0.08) $0.03 $0.05 ($0.05) ($0.09) $0.07 $0.03
Adjusted Weighted Average Basic Shares Outstanding		 31.19M 31.23M 33.85M 33.91M 38.14M 38.16M 45.02M 49.12M 49.56M 62.35M 70.34M
Adjusted Diluted Earnings per Share		 ($0.04) ($0.04) ($0.03) ($0.06) ($0.08) $0.03 $0.05 ($0.05) ($0.09) $0.07 $0.02
Adjusted Weighted Average Diluted Shares Outstanding		 31.19M 31.23M 33.85M 33.91M 38.14M 38.55M 47.04M 49.12M 49.56M 65.03M 72.58M
Adjusted Basic & Diluted Earnings per Share		 ($0.04) ($0.04) ($0.03) ($0.06) ($0.08) $0.00 $0.00 $0.00 $0.00 $0.00 $0.00
Adjusted Weighted Average Basic & Diluted Shares Outstanding		 28.57M 30.91M 31.34M 33.87M 36.60M 38.22M 48.89M 49.51M 54.80M 70.10M 70.63M
Normalized Net Operating Profit after Tax (NOPAT)		 -0.82 -0.89 -0.54 -1.42 -1.96 1.04 2.52 -1.58 -2.48 4.87 1.51
Normalized NOPAT Margin		 -8.00% -8.23% -3.12% -9.98% -15.65% 6.07% 8.55% -4.24% -6.66% 9.31% 2.43%
Pre Tax Income Margin		 -11.56% -11.90% -4.56% -14.66% -24.03% 5.78% 8.00% -7.07% -11.75% 8.52% 3.00%
Debt Service Ratios		 - - - - - - - - - - -
EBIT to Interest Expense		 -84.14 -84.53 -22.21 -34.88 -13.31 2.99 3.04 -5.91 -4.23 0.00 0.00
NOPAT to Interest Expense		 -58.90 -59.17 -15.89 -24.42 -9.32 2.99 2.18 -4.14 -2.96 0.00 0.00
EBIT Less CapEx to Interest Expense		 -104.71 -95.53 -24.32 -37.64 -16.84 1.22 1.42 -13.30 -5.49 0.00 0.00
NOPAT Less CapEx to Interest Expense		 -79.47 -70.17 -18.01 -27.17 -12.84 1.22 0.56 -11.53 -4.22 0.00 0.00
Payout Ratios		 - - - - - - - - - - -
Dividend Payout Ratio		 0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00%
Augmented Payout Ratio		 0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00%

Quarterly Metrics And Ratios for Solesence

This table displays calculated financial ratios and metrics derived from Solesence's official financial filings.

Metric Q3 2023 Q4 2023 Q1 2024 Q2 2024 Q3 2024 Q4 2024 Q1 2025 Q2 2025 Q3 2025 Q4 2025 Q1 2026
Period end date 9/30/2023 12/31/2023 3/31/2024 6/30/2024 9/30/2024 12/31/2024 3/31/2025 6/30/2025 9/30/2025 12/31/2025 3/31/2026
DEI Shares Outstanding		 49,589,204.00 49,627,254.00 54,801,834.00 54,860,984.00 69,860,984.00 69,994,979.00 70,103,279.00 70,103,279.00 70,481,945.00 70,536,845.00 70,632,445.00
DEI Adjusted Shares Outstanding		 49,589,204.00 49,627,254.00 54,801,834.00 54,860,984.00 69,860,984.00 69,994,979.00 70,103,279.00 70,103,279.00 70,481,945.00 70,536,845.00 70,632,445.00
DEI Earnings Per Adjusted Shares Outstanding		 -0.03 -0.04 0.02 0.02 0.04 -0.01 0.00 0.04 -0.02 0.00 -0.01
Growth Metrics		 - - - - - - - - - - -
Revenue Growth		 -17.77% -3.04% 4.35% 9.89% 111.94% 56.89% 48.21% 56.06% -13.45% -0.67% -11.41%
EBITDA Growth		 -112.20% 1.00% 262.05% 70.71% 428.45% 100.24% -64.16% 162.79% -116.21% 10,100.00% -139.42%
EBIT Growth		 -92.74% -2.54% 210.66% 80.83% 361.70% 88.20% -76.96% 200.29% -124.42% 183.48% -296.48%
NOPAT Growth		 -92.74% -2.54% 258.08% 80.83% 473.86% 88.20% -76.96% 59.15% -117.10% 183.48% -237.81%
Net Income Growth		 -91.47% -7.20% 177.05% 157.06% 312.05% 73.73% -91.04% 211.57% -136.78% 129.16% -1,057.50%
EPS Growth		 -50.00% -66.67% 200.00% 0.00% 233.33% 0.00% -100.00% 300.00% -150.00% 0.00% 0.00%
Operating Cash Flow Growth		 164.74% -454.75% -392.97% 52.08% 61.31% 182.60% -87.32% -15.75% -159.76% -16.90% 121.01%
Free Cash Flow Firm Growth		 14.68% 51.80% -3.58% 37.88% 101.90% -28.62% -26.32% -254.14% -57,004.86% -604.05% -120.01%
Invested Capital Growth		 10.89% 4.61% 40.26% 29.84% 31.38% 18.31% 29.08% 70.08% 146.25% 117.47% 45.13%
Revenue Q/Q Growth		 -32.97% 0.65% 23.20% 32.21% 29.28% -25.49% 16.38% 39.21% -28.30% -14.48% 3.80%
EBITDA Q/Q Growth		 -239.01% -61.02% 180.01% -4.68% 167.47% -99.88% 11,950.00% 598.96% -116.50% 173.38% -146.57%
EBIT Q/Q Growth		 -311.05% -55.40% 158.50% -5.76% 205.44% -107.00% 214.29% 1,128.13% -124.84% 123.94% -368.98%
NOPAT Q/Q Growth		 -247.74% -55.40% 183.58% -5.76% 205.44% -104.90% 263.27% 550.91% -132.81% 123.94% -369.52%
Net Income Q/Q Growth		 -531.23% -48.19% 141.96% -4.14% 255.72% -118.36% 114.31% 3,233.75% -141.99% 114.55% -569.94%
EPS Q/Q Growth		 -400.00% -66.67% 140.00% -50.00% 300.00% 0.00% 0.00% 0.00% -150.00% 0.00% 0.00%
Operating Cash Flow Q/Q Growth		 320.95% -201.73% -45.47% 85.34% 843.72% -47.91% -429.88% 90.94% -283.95% 172.44% -16.60%
Free Cash Flow Firm Q/Q Growth		 63.01% -1.40% -85.81% 10.87% 101.13% -6,976.57% -82.48% -149.88% -81.48% 14.92% 42.98%
Invested Capital Q/Q Growth		 -27.43% 21.88% 30.08% 12.86% -26.58% 9.76% 41.92% 48.70% 6.31% -3.07% -5.29%
Profitability Metrics		 - - - - - - - - - - -
Gross Margin		 19.23% 5.88% 36.28% 28.67% 36.18% 22.01% 23.12% 28.87% 23.09% 27.51% 25.75%
EBITDA Margin		 -13.12% -20.99% 13.63% 9.83% 20.33% 0.03% 3.30% 16.55% -3.81% 3.27% -1.47%
Operating Margin		 -15.36% -23.71% 11.26% 8.03% 18.96% -1.78% 1.75% 9.38% -5.35% 1.50% -3.89%
EBIT Margin		 -15.36% -23.71% 11.26% 8.03% 18.96% -1.78% 1.75% 15.44% -5.35% 1.50% -3.88%
Profit (Net Income) Margin		 -18.04% -26.57% 9.05% 6.56% 18.05% -4.45% 0.55% 13.10% -7.67% 1.31% -5.91%
Tax Burden Percent		 100.00% 100.28% 100.00% 100.00% 100.00% 168.37% 100.00% 87.24% 100.00% -105.84% 100.00%
Interest Burden Percent		 117.51% 111.74% 80.38% 81.76% 95.22% 148.21% 31.25% 97.23% 143.41% -82.35% 152.29%
Effective Tax Rate		 0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 12.76% 0.00% 0.00% 0.00%
Return on Invested Capital (ROIC)		 -42.10% -51.51% 31.01% 19.55% 77.70% -4.87% 5.46% 21.64% -10.15% 2.82% -6.50%
ROIC Less NNEP Spread (ROIC-NNEP)		 -56.95% -61.20% 27.33% 16.97% 70.46% -12.93% 2.11% 32.40% -18.67% 3.29% -10.98%
Return on Net Nonoperating Assets (RNNOA)		 -39.25% -133.59% 20.79% 14.75% 15.59% -7.66% 0.85% 20.02% -7.76% 1.37% -6.31%
Return on Equity (ROE)		 -81.35% -185.10% 51.81% 34.30% 93.28% -12.53% 6.31% 41.66% -17.91% 4.19% -12.81%
Cash Return on Invested Capital (CROIC)		 -35.88% -25.17% -40.83% -30.19% 2.45% 19.54% -3.48% -33.02% -81.27% -67.46% -33.84%
Operating Return on Assets (OROA)		 -17.37% -26.62% 12.13% 8.30% 22.54% -2.25% 2.09% 19.74% -6.52% 1.86% -4.47%
Return on Assets (ROA)		 -20.41% -29.83% 9.75% 6.79% 21.46% -5.62% 0.65% 16.74% -9.35% 1.62% -6.81%
Return on Common Equity (ROCE)		 -81.35% -185.10% 31.81% 34.30% 93.28% -12.53% 4.86% 41.66% -17.91% 4.19% -12.81%
Return on Equity Simple (ROE_SIMPLE)		 -108.04% 0.00% -47.22% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00%
Net Operating Profit after Tax (NOPAT)		 -0.86 -1.33 1.11 1.05 3.20 -0.16 0.26 1.67 -0.55 0.13 -0.35
NOPAT Margin		 -10.75% -16.60% 11.26% 8.03% 18.96% -1.25% 1.75% 8.18% -3.75% 1.05% -2.72%
Net Nonoperating Expense Percent (NNEP)		 14.85% 9.69% 3.69% 2.57% 7.24% 8.06% 3.35% -10.76% 8.52% -0.47% 4.48%
Return On Investment Capital (ROIC_SIMPLE)		 - -9.49% 9.26% 5.13% 19.78% -0.98% 1.14% 4.79% -1.65% 0.40% -1.16%
Cost of Revenue to Revenue		 80.77% 94.12% 63.72% 71.33% 63.82% 77.99% 76.88% 71.13% 76.91% 72.49% 74.25%
SG&A Expenses to Revenue		 21.30% 19.78% 15.80% 14.02% 11.47% 15.10% 14.41% 14.79% 21.02% 17.72% 21.60%
R&D to Revenue		 13.28% 9.81% 9.22% 6.62% 5.75% 8.70% 6.96% 4.69% 7.41% 8.29% 8.04%
Operating Expenses to Revenue		 34.58% 29.59% 25.02% 20.64% 17.22% 23.79% 21.37% 19.49% 28.44% 26.01% 29.64%
Earnings before Interest and Taxes (EBIT)		 -1.22 -1.90 1.11 1.05 3.20 -0.22 0.26 3.14 -0.78 0.19 -0.50
Earnings before Interest, Taxes, Depreciation and Amortization (EBITDA)		 -1.04 -1.68 1.35 1.28 3.43 0.00 0.48 3.37 -0.56 0.41 -0.19
Valuation Ratios		 - - - - - - - - - - -
Price to Book Value (P/BV)		 11.04 15.63 8.22 7.63 7.70 10.63 9.82 17.40 13.18 6.56 3.95
Price to Tangible Book Value (P/TBV)		 11.04 15.63 8.22 7.63 7.70 10.63 9.82 17.40 13.18 6.56 3.95
Price to Revenue (P/Rev)		 1.16 0.80 1.08 2.34 2.44 3.03 2.61 4.91 3.65 1.87 1.11
Price to Earnings (P/E)		 0.00 0.00 0.00 0.00 43.80 37.51 43.51 60.47 212.56 64.67 70.97
Dividend Yield		 0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00%
Earnings Yield		 0.00% 0.00% 0.00% 0.00% 2.28% 2.67% 2.30% 1.65% 0.47% 1.55% 1.41%
Enterprise Value to Invested Capital (EV/IC)		 4.92 3.27 3.24 5.38 8.67 10.90 7.48 10.72 7.43 4.10 2.67
Enterprise Value to Revenue (EV/Rev)		 1.32 1.08 1.37 2.50 2.40 3.03 2.70 5.11 3.90 2.09 1.32
Enterprise Value to EBITDA (EV/EBITDA)		 0.00 0.00 0.00 0.00 26.25 26.15 29.70 54.37 117.39 35.15 26.49
Enterprise Value to EBIT (EV/EBIT)		 0.00 0.00 0.00 0.00 33.22 30.88 36.09 64.00 208.79 46.44 39.30
Enterprise Value to NOPAT (EV/NOPAT)		 0.00 0.00 0.00 0.00 33.29 32.53 38.49 71.54 329.40 85.90 106.10
Enterprise Value to Operating Cash Flow (EV/OCF)		 35.62 0.00 0.00 0.00 0.00 80.39 0.00 0.00 0.00 0.00 467.66
Enterprise Value to Free Cash Flow (EV/FCFF)		 0.00 0.00 0.00 0.00 401.21 60.46 0.00 0.00 0.00 0.00 0.00
Leverage & Solvency		 - - - - - - - - - - -
Debt to Equity		 1.87 6.37 0.64 0.71 0.07 0.07 0.48 0.91 0.92 0.87 0.80
Long-Term Debt to Equity		 0.25 3.15 0.57 0.52 0.00 0.00 0.00 0.58 0.61 0.60 0.62
Financial Leverage		 0.69 2.18 0.76 0.87 0.22 0.59 0.40 0.62 0.42 0.42 0.57
Leverage Ratio		 5.85 8.80 4.50 4.40 4.21 4.92 3.66 3.35 3.15 3.07 3.26
Compound Leverage Factor		 6.87 9.83 3.62 3.60 4.01 7.29 1.14 3.26 4.52 -2.53 4.97
Debt to Total Capital		 65.12% 86.42% 39.16% 41.54% 6.18% 6.27% 32.48% 47.72% 47.86% 46.40% 44.40%
Short-Term Debt to Total Capital		 56.24% 43.59% 4.72% 11.14% 6.18% 6.27% 32.48% 17.53% 16.09% 14.49% 9.99%
Long-Term Debt to Total Capital		 8.87% 42.83% 34.44% 30.40% 0.00% 0.00% 0.00% 30.18% 31.78% 31.91% 34.41%
Preferred Equity to Total Capital		 0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00%
Noncontrolling Interests to Total Capital		 0.00% 0.00% 33.33% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00%
Common Equity to Total Capital		 34.88% 13.58% 27.50% 58.46% 93.82% 93.73% 67.52% 52.28% 52.14% 53.60% 55.60%
Debt to EBITDA		 -2.60 -4.32 -11.21 -86.45 0.23 0.17 1.40 2.74 7.66 4.14 4.49
Net Debt to EBITDA		 -2.18 -3.70 -8.00 -62.39 -0.44 -0.07 1.05 2.06 7.45 3.79 4.30
Long-Term Debt to EBITDA		 -0.35 -2.14 -9.86 -63.27 0.00 0.00 0.00 1.74 5.08 2.84 3.48
Debt to NOPAT		 -3.00 -4.88 -7.04 -12.57 0.29 0.21 1.82 3.61 21.49 10.11 17.97
Net Debt to NOPAT		 -2.51 -4.18 -5.02 -9.07 -0.56 -0.08 1.37 2.72 20.91 9.26 17.21
Long-Term Debt to NOPAT		 -0.41 -2.42 -6.19 -9.20 0.00 0.00 0.00 2.28 14.27 6.95 13.93
Altman Z-Score		 -2.56 -2.91 -1.50 -0.29 0.60 1.03 0.75 3.84 2.58 0.99 -0.03
Noncontrolling Interest Sharing Ratio		 0.00% 0.00% 38.59% 0.00% 0.00% 0.00% 22.98% 0.00% 0.00% 0.00% 0.00%
Liquidity Ratios		 - - - - - - - - - - -
Current Ratio		 0.88 1.05 1.81 1.76 1.28 1.14 1.09 1.72 1.84 2.07 2.08
Quick Ratio		 0.25 0.33 0.60 0.60 0.50 0.24 0.33 0.67 0.57 0.58 0.55
Cash Flow Metrics		 - - - - - - - - - - -
Free Cash Flow to Firm (FCFF)		 -1.85 -1.87 -3.48 -3.10 0.04 -2.41 -4.39 -11 -20 -17 -9.66
Operating Cash Flow to CapEx		 6,353.66% -1,331.66% -4,535.29% -118.45% 299.50% 84.42% 0.00% -46.45% -600.72% 404.22% 287.31%
Free Cash Flow to Firm to Interest Expense		 -8.62 -8.39 -15.95 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00
Operating Cash Flow to Interest Expense		 12.17 -11.88 -17.68 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00
Operating Cash Flow Less CapEx to Interest Expense		 11.98 -12.78 -18.07 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00
Efficiency Ratios		 - - - - - - - - - - -
Asset Turnover		 1.13 1.12 1.08 1.03 1.19 1.26 1.20 1.28 1.22 1.24 1.15
Accounts Receivable Turnover		 8.77 9.10 7.81 6.68 8.01 12.56 7.95 7.59 6.74 10.60 7.81
Inventory Turnover		 2.96 3.12 2.66 2.65 2.69 2.39 2.34 2.75 2.76 2.37 2.25
Fixed Asset Turnover		 4.96 4.49 4.43 4.39 5.07 4.89 5.21 5.65 5.14 4.59 4.34
Accounts Payable Turnover		 3.43 4.67 4.65 5.61 5.28 4.71 5.35 7.43 8.21 6.97 6.41
Days Sales Outstanding (DSO)		 41.64 40.13 46.76 54.68 45.56 29.06 45.92 48.11 54.15 34.42 46.73
Days Inventory Outstanding (DIO)		 123.11 116.85 137.26 137.59 135.49 152.92 156.22 132.89 132.38 153.84 162.32
Days Payable Outstanding (DPO)		 106.29 78.17 78.56 65.03 69.09 77.49 68.29 49.16 44.45 52.33 56.92
Cash Conversion Cycle (CCC)		 58.47 78.81 105.46 127.23 111.97 104.49 133.85 131.84 142.08 135.93 152.13
Capital & Investment Metrics		 - - - - - - - - - - -
Invested Capital		 10 12 16 18 13 15 21 31 33 32 30
Invested Capital Turnover		 3.92 3.10 2.75 2.44 4.10 3.90 3.12 2.64 2.71 2.69 2.39
Increase / (Decrease) in Invested Capital		 0.99 0.54 4.59 4.15 3.16 2.25 4.65 13 19 17 9.31
Enterprise Value (EV)		 50 40 52 97 115 158 154 329 242 130 80
Market Capitalization		 43 30 41 91 117 159 149 316 227 116 67
Book Value per Share		 $0.08 $0.04 $0.09 $0.22 $0.22 $0.21 $0.22 $0.26 $0.24 $0.25 $0.24
Tangible Book Value per Share		 $0.08 $0.04 $0.09 $0.22 $0.22 $0.21 $0.22 $0.26 $0.24 $0.25 $0.24
Total Capital		 11 14 18 20 16 16 22 35 33 33 31
Total Debt		 7.34 12 7.05 8.47 1.00 1.00 7.29 17 16 15 14
Total Long-Term Debt		 1.00 6.00 6.20 6.20 0.00 0.00 0.00 11 11 11 11
Net Debt		 6.15 10 5.03 6.11 -1.93 -0.41 5.48 12 15 14 13
Capital Expenditures (CapEx)		 0.04 0.20 0.09 0.48 1.40 2.59 -0.13 1.41 0.42 0.45 0.53
Debt-free, Cash-free Net Working Capital (DFCFNWC)		 3.04 5.10 8.73 10 4.55 3.17 8.50 18 20 18 16
Debt-free Net Working Capital (DFNWC)		 4.23 6.82 11 13 7.47 4.58 10 22 20 20 17
Net Working Capital (NWC)		 -2.11 0.71 9.90 10 6.47 3.58 3.03 16 15 15 14
Net Nonoperating Expense (NNE)		 0.58 0.80 0.22 0.19 0.15 0.40 0.18 -1.00 0.57 -0.03 0.41
Net Nonoperating Obligations (NNO)		 6.15 10 5.03 6.11 -1.93 -0.41 5.48 12 15 14 13
Total Depreciation and Amortization (D&A)		 0.18 0.22 0.23 0.24 0.23 0.23 0.23 0.23 0.23 0.22 0.31
Debt-free, Cash-free Net Working Capital to Revenue		 8.10% 13.67% 23.16% 26.76% 9.52% 6.05% 14.89% 28.29% 31.88% 29.53% 26.82%
Debt-free Net Working Capital to Revenue		 11.26% 18.29% 28.51% 32.83% 15.64% 8.74% 18.07% 34.67% 32.57% 31.60% 27.77%
Net Working Capital to Revenue		 -5.62% 1.91% 26.25% 26.98% 13.54% 6.83% 5.30% 25.20% 24.02% 23.92% 22.72%
Earnings Adjustments		 - - - - - - - - - - -
Adjusted Basic Earnings per Share		 ($0.03) ($0.05) $0.02 $0.02 $0.04 ($0.01) $0.00 $0.04 ($0.02) $0.01 ($0.01)
Adjusted Weighted Average Basic Shares Outstanding		 49.60M 49.56M 52.68M 56.67M 69.87M 62.35M 70.10M 70.20M 70.50M 70.34M 70.63M
Adjusted Diluted Earnings per Share		 ($0.03) ($0.05) $0.02 $0.01 $0.04 $0.00 $0.00 $0.04 ($0.02) $0.00 ($0.01)
Adjusted Weighted Average Diluted Shares Outstanding		 49.60M 49.56M 58.04M 58.71M 71.94M 65.03M 72.63M 72.58M 70.50M 72.58M 70.63M
Adjusted Basic & Diluted Earnings per Share		 $0.00 $0.00 $0.00 $0.00 $0.00 $0.00 $0.00 $0.00 $0.00 $0.00 $0.00
Adjusted Weighted Average Basic & Diluted Shares Outstanding		 49.63M 54.80M 54.86M 69.86M 69.99M 70.10M 70.10M 70.48M 70.54M 70.63M 70.63M
Normalized Net Operating Profit after Tax (NOPAT)		 -0.86 -1.33 0.78 0.73 2.24 -0.16 0.18 1.67 -0.55 0.13 -0.35
Normalized NOPAT Margin		 -10.75% -16.60% 7.88% 5.62% 13.27% -1.25% 1.23% 8.18% -3.75% 1.05% -2.72%
Pre Tax Income Margin		 -18.04% -26.49% 9.05% 6.56% 18.05% -2.64% 0.55% 15.02% -7.67% -1.23% -5.91%
Debt Service Ratios		 - - - - - - - - - - -
EBIT to Interest Expense		 -5.71 -8.52 5.10 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00
NOPAT to Interest Expense		 -4.00 -5.96 5.10 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00
EBIT Less CapEx to Interest Expense		 -5.90 -9.41 4.71 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00
NOPAT Less CapEx to Interest Expense		 -4.19 -6.85 4.71 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00
Payout Ratios		 - - - - - - - - - - -
Dividend Payout Ratio		 0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00%
Augmented Payout Ratio		 0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00%

Financials Breakdown Chart

Key Financial Trends

Solesence (NASDAQ: SLSN) delivered a mixed first quarter of 2026: revenue grew modestly year over year, operating cash flow turned positive, and the company made progress on debt reduction. However, the quarter still ended with a net loss, negative free cash flow, and a sharply weaker cash balance than at the end of 2025.

  • Revenue rose year over year: Q1 2026 revenue increased to $12.96 million from $12.48 million in Q4 2025 and $9.87 million in Q1 2024, showing a longer-term top-line recovery.
  • Operating cash flow improved: The company generated $1.52 million in operating cash flow in Q1 2026, a significant improvement from a $2.51 million outflow in Q3 2025 and a $7.22 million outflow in Q1 2025.
  • Gross profit remained positive: Gross profit was $3.34 million, with gross margin around 25.8%, which shows the business still clears product-level profitability before overhead.
  • Debt was reduced: Solesence repaid $1.72 million of debt in Q1 2026, indicating management is trying to deleverage the balance sheet.
  • Quarterly loss narrowed versus much of 2025: Net loss was $766,000, smaller than the $1.12 million loss in Q3 2025 and far better than the severe losses seen earlier in the year.
  • Expenses remain elevated: SG&A of $2.80 million and R&D of $1.04 million consumed most of gross profit, keeping operating income slightly negative at $504,000.
  • Inventory remains large: Inventory stood at $17.56 million, which is a sizable working-capital investment relative to quarterly revenue.
  • Interest costs are still meaningful: Cash interest paid was $173,000 in the quarter, and the company also reported negative interest and investment income.
  • Shares outstanding were relatively stable: Basic and diluted weighted average shares were both about 70.6 million, so dilution was limited in the quarter.
  • Cash balance declined sharply: Cash and equivalents fell to $573,000 from $4.11 million at Q2 2025 and $1.82 million at Q1 2025, reducing near-term liquidity.
  • Free cash flow was negative: After $528,000 of capital spending, the company still generated a net cash outflow from investing activities, which offsets some of the operating improvement.
  • Balance sheet leverage remains high: Total liabilities were $30.83 million versus $16.97 million of equity, so the company is still carrying a heavily debt- and obligation-laden balance sheet.
  • Working capital pressure is still visible: The company’s current liabilities of $12.69 million remain significant relative to only $26.41 million of current assets, limiting liquidity cushion.

Bottom line: Q1 2026 showed better operational traction, especially at the cash flow level, but Solesence is not yet in a comfortable financial position. Investors will likely want to see continued revenue growth, sustained positive operating cash flow, and further balance sheet improvement before calling the turnaround durable.

07/18/26 01:22 PM ETAI Generated. May Contain Errors.

Solesence Financials - Frequently Asked Questions

According to the most recent income statement we have on file, Solesence's financial year ends in December. Their financial year 2025 ended on December 31, 2025.

Solesence's net income appears to be on a downward trend, with a most recent value of $1.79 million in 2025, falling from -$1.19 million in 2015. The previous period was $4.24 million in 2024. View Solesence's forecast to see where analysts expect Solesence to go next.

Solesence's total operating income in 2025 was $1.57 million, based on the following breakdown:
  • Total Gross Profit: $16.06 million
  • Total Operating Expenses: $14.49 million

Over the last 10 years, Solesence's total revenue changed from $10.31 million in 2015 to $62.06 million in 2025, a change of 501.8%.

Solesence's total liabilities were at $32.42 million at the end of 2025, a 7.5% decrease from 2024, and a 1,792.6% increase since 2015.

In the past 10 years, Solesence's cash and equivalents has ranged from $657 thousand in 2021 to $2.19 million in 2022, and is currently $1.29 million as of their latest financial filing in 2025.

Over the last 10 years, Solesence's book value per share changed from 0.10 in 2015 to 0.25 in 2025, a change of 149.8%.


Related Companies

Financial statements for NASDAQ:SLSN last updated on 7/16/2026 by MarketBeat.com Staff. New filings and market data are monitored continuously.
From Our Partners
Trump's gold order: the announcement they won't put on the front page
On August 15, 1971, Nixon interrupted prime-time television and ended the gold standard in 15 minutes - no deb...
Reagan Gold Group | Sponsoredtc pixel
The only metrics you should watch as a day trader.
Day traders and swing traders don't need the same metrics - and using the wrong ones costs you edge. After 40 ...
The TradingPub | Sponsoredtc pixel
Your withdrawal order could cost you in taxes
If you have $2M or more saved, the 4% rule points to roughly $92,000 a year - but it's a single-variable answe...
SmartAsset | Sponsoredtc pixel
#1 Question to Ask Your Bank Today
Elon Musk's new banking platform is paying up to 15 times the national average interest rate while insuring de...
InvestorPlace | Sponsoredtc pixel
Buy this stock tomorrow
Marc Chaikin, founder of Chaikin Analytics, is flagging a little-known company that just secured a partnership...
Chaikin Analytics | Sponsoredtc pixel
SPCX Warning - and Worst News for Stocks in 50 Years
Goldman Sachs and Morgan Stanley are now predicting what could be the worst news for the U.S. stock market in ...
TradeSmith | Sponsoredtc pixel
Iran War Shock: What I Was Told In That Private Meeting
You’re Being LIED To About The Iran War Forget EVERYTHING you’ve heard about the Iran war. Especially th...
Banyan Hill Publishing | Sponsoredtc pixel
URGENT Dollar Reset Warning for Monday
A 50-year U.S.-Saudi arrangement established under Henry Kissinger - one credited with anchoring the dollar in...
Golden Portfolio | Sponsoredtc pixel